Apollo Endosurgery Inc (APEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,752 | -1,102 | -1 | 646 | -3,114 |
| Depreciation Amortization | 188 | 75 | 47 | 22 | 142 |
| Accounts receivable | 1,101 | 962 | 692 | -2,062 | 14,056 |
| Other Working Capital | -3,497 | -3,166 | -2,195 | -3,688 | 10,860 |
| Other Operating Activity | -3,352 | -3,066 | -2,723 | 313 | -13,882 |
| Operating Cash Flow | $-8,313 | $-6,298 | $-4,180 | $-4,770 | $8,062 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -155 | -155 | -92 | -19 | -134 |
| Purchase Sale Intangibles | -190 | -150 | -108 | -47 | -355 |
| Other Investing Activity | -190 | -150 | -108 | -47 | -355 |
| Investing Cash Flow | $-344 | $-305 | $-199 | $-66 | $-489 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 19,153 | 8,212 | 8,212 | 8,212 | 34 |
| Other Financing Activity | -285 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $18,868 | $8,212 | $8,212 | $8,212 | $34 |
| Beginning Cash Position | 14,411 | 14,411 | 14,411 | 14,411 | 6,804 |
| End Cash Position | 24,621 | 16,020 | 18,244 | 17,786 | 14,411 |
| Net Cash Flow | $10,211 | $1,610 | $3,833 | $3,376 | $7,607 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,313 | -6,298 | -4,180 | -4,770 | 8,062 |
| Capital Expenditure | -155 | -155 | -92 | -19 | -134 |
| Free Cash Flow | -8,468 | -6,452 | -4,271 | -4,789 | 7,928 |